FRI0113 Coronary athero-protection against high-risk mixed plaque (MP) independently of good disease...
FRI0113 Coronary athero-protection against high-risk mixed plaque (MP) independently of good disease response in coronary artery disease (CAD)-naÏve patients with rheumatoid arthritis receiving tumor necrosis factor-a (TNFA) inhibitors
About this item
Full title
Author / Creator
Karpouzas, G.A. , Malpeso, J. , Choi, T.-Y. , Li, D. , Munoz, S. and Budoff, M.
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
More information
Scope and Contents
Contents
Background TNFa is a pivotal cytokine in the pathophysiology and progression of both RA and atherosclerosis. Addition of TNFa inhibitors (TNFi) to disease modifying agents (DMARDs) superiorly controls clinical inflammation and radiographic progression in RA. Non-invasive, accurate evaluation of coronary plaque is feasible with computed tomography a...
Alternative Titles
Full title
FRI0113 Coronary athero-protection against high-risk mixed plaque (MP) independently of good disease response in coronary artery disease (CAD)-naÏve patients with rheumatoid arthritis receiving tumor necrosis factor-a (TNFA) inhibitors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1777973068
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777973068
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2012-eular.2570
